NCBI Taxonomy: 679429
Fusarium tricinctum species complex (ncbi_taxid: 679429)
found 83 associated metabolites at species group taxonomy rank level.
Ancestor: Fusarium
Child Taxonomies: Fusarium avenaceum, Fusarium tricinctum, Fusarium acuminatum, Fusarium gamsii, Fusarium flocciferum, Fusarium alpinum, Fusarium iranicum, Fusarium paeoniae, Fusarium petersiae, Fusarium chongqingense, unclassified Fusarium tricinctum species complex
T2 Toxin
T2 Toxin is isolated from Fusarium species and Trichoderma lignorum. T2 Toxin is an important mycotoxin occurring naturally in various agricultural products. Isolated from Fusarium subspecies and Trichoderma lignorum. Important mycotoxin occurring naturally in various agricultural products D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins T-2 Toxin (T-2 Mycotoxin) is a toxic trichothecene mycotoxin produced by various Fusarium species in feedstuffs and cereal grains, LD50 values of T-2 Toxin in mice and rats are 5.2 and 1.5 mg/kg BWa,respectively [1]. T-2 Toxin (T-2 Mycotoxin) can be transformed into a variety of metabolite, the typical metabolites of T-2 toxin in animals are HT-2 toxin and T-2-triol, which are hydrolysates[1]. T-2 Toxin (T-2 Mycotoxin) is an inhibitor of protein synthesis resulting from binding peptidyltransferase, which is an integral part of the 60s ribosomal subunit. T-2 Toxin (T-2 Mycotoxin) inhibits the synthesis of DNA and RNA, interferes with the metabolism of membrane phospholipids, and increases the level of liver lipid peroxides[1]. T-2 Toxin (T-2 Mycotoxin) induces apoptosis in the immune system, gastrointestinal tissues, and fetal tissues[2].
3,9,15-Tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
[Raw Data] CBA19_Beauvericin_pos_20eV_1-1_01_1374.txt [Raw Data] CBA19_Beauvericin_pos_50eV_1-1_01_1485.txt [Raw Data] CBA19_Beauvericin_pos_10eV_1-1_01_1352.txt [Raw Data] CBA19_Beauvericin_pos_40eV_1-1_01_1376.txt [Raw Data] CBA19_Beauvericin_pos_30eV_1-1_01_1483.txt Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1]. Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1].
Enniatin B
An enniatin obtained from formal cyclocondensation of three N-[(2R)-2-hydroxy-3-methylbutanoyl]-N-methyl-L-valine units. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE Reference Standard (Level 1)
Nivalenol
Nivalenol is a trichothecene produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants. They may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition.(PubChem). It has been reported in the urine of patients suffering chronic idiopathic spastic paraparesis. These patients are usually found in hot and humid regions, most of which have heavy rains, and these conditions allow foods to be polluted by fungi some of which become toxigenic (PubMed ID 8855894 ). Nivalenol is a trichothecene produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants. They may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition.(PubChem) D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Enniatin B
6-(3-hydroxybutan-2-yl)-5-(hydroxymethyl)-4-methoxypyran-2-one
Beauvericin
A trimeric cyclodepsipeptide composed from alternating methylphenylalanyl and hydroxyvaleryl residues. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2334 CONFIDENCE Reference Standard (Level 1) Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1]. Beauvericin is a Fusarium mycotoxin. Beauvericin inhibits acyl-CoA: cholesterol acyltransferase (ACAT) activity with an IC50 of 3 μM in an enzyme assay using rat liver microsomes[1].
Enniatin A1
An enniatin obtained from formal cyclocondensation of one N-[(2R)-2-hydroxy-3-methylbutanoyl]-N-methyl-L-valine and two N-[(2R)-2-hydroxy-3-methylbutanoyl]-N-methyl-L-isoleucine units. CONFIDENCE Reference Standard (Level 1)
CID 440908
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Reference Standard (Level 1)
fusafungine
R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AB - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
8-Hydroxydiacetoxyscirpenol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
methyl 11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
C22H27NO7 (417.17874320000004)
methyl 5,9-dihydroxy-2-methyl-4,6-dioxopyrano[3,4-g]chromene-8-carboxylate
(7r,8s)-8-bromo-4,7-dimethoxy-7,8-dimethyl-5h-pyrano[3,2-c]pyran-2-one
3-{5,9,12-trihydroxy-6,13-dimethyl-10-methylidene-2-oxo-14-[(5e,7e)-3,7,11-trimethyl-4-oxoheptadeca-5,7-dien-1-yl]-1-oxa-4,8,11-triazacyclotetradeca-4,8,11-trien-3-yl}propanimidic acid
C36H58N4O7 (658.4305277999999)
(7r,8s)-7-hydroxy-4-methoxy-7,8-dimethyl-5h,8h-pyrano[3,2-c]pyran-2-one
3-[(2s,3z,5r,6e,8e)-1,2-dihydroxydeca-3,6,8-trien-5-yl]-4-hydroxy-5-methylidenefuran-2-one
(10'r,11's)-3',10'-dihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-4'-oxo-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(1's,2'r,4's,7'r,9'r,10'r,11's)-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-4',10',11'-triol
(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-3-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate
(1's,2s,2'r,3's,7'r,9'r,10'r,11's)-3',10'-dihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-4'-oxo-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
beauvericin
{"Ingredient_id": "HBIN017671","Ingredient_name": "beauvericin","Alias": "NA","Ingredient_formula": "C45H57N3O9","Ingredient_Smile": "CC(C)C1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC2=CC=CC=C2)C)C(C)C)CC3=CC=CC=C3)C)C(C)C)CC4=CC=CC=C4)C","Ingredient_weight": "783.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2188","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44419427","DrugBank_id": "NA"}
(3s,6r,9s,12r,15s,18r)-6,12,18-triisopropyl-4,10,16-trimethyl-3-(2-methylpropyl)-9,15-bis(sec-butyl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
C36H63N3O9 (681.4564068000001)
(2'r,4's,10'r,11's)-11'-(acetyloxy)-4',10'-dihydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
(3s,6r,9s,12r,15s,18r)-3,6,9,12,18-pentaisopropyl-4,10,16-trimethyl-15-(sec-butyl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
3-[2-(morpholin-4-yl)ethyl]naphtho[2,1-d][1,2]oxazole-6-carboxylic acid
C18H18N2O4 (326.12665080000005)
(1'r,2s,2'r,4's,7'r,9'r,10'r,11's)-4'-(acetyloxy)-10'-hydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
8-bromo-4,7-dimethoxy-7,8-dimethyl-5h-pyrano[3,2-c]pyran-2-one
2-(but-2-en-2-yl)-6-hydroxy-1a,6-dimethyl-3-[4-(2,2,5-trimethyl-1,3-dioxan-4-yl)penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate
5-(but-2-en-2-yl)-4,11-dimethyl-6-[4-(2,2,5-trimethyl-1,3-dioxan-4-yl)penta-1,3-dien-1-yl]-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecane
(5e,7r,10s)-7-isopropyl-4-methylideneundec-5-ene-1,10-diol
3-[(2r,4r)-2,4-dihydroxypentyl]-6,8-dihydroxyisochromen-1-one
(1s,2r,3r,5r,6s,9r)-2,3-dihydroxy-3-methyl-9-[(1e,3e)-penta-1,3-dien-1-yl]-4,11-dioxatricyclo[4.3.2.0¹,⁵]undec-7-en-10-one
(2'r,3's,7'r,9'r,10'r,11's)-3',10',11'-trihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-4'-one
(3s,6r,9s,12r,18r)-3,9,15-tris[(2s)-butan-2-yl]-6,12,18-triisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
C36H63N3O9 (681.4564068000001)
(1'r,2r,2's,9's,10'r,11'r)-11'-(acetyloxy)-10'-hydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
17-hydroxy-3,6,9,12,15,18-hexaisopropyl-4,10-dimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadec-16-ene-2,5,8,11,14-pentone
(1s,2r,3s,5r,6s,9r)-2,3-dihydroxy-3-methyl-9-[(1e,3e)-penta-1,3-dien-1-yl]-4,11-dioxatricyclo[4.3.2.0¹,⁵]undec-7-en-10-one
2-(2-{[2-(2-hydroxy-n,3-dimethylbutanamido)-3-methylbutanoyl]oxy}-n,3-dimethylbutanamido)-3-methylbutanoic acid
(1's,2s,2'r,4's,7'r,9'r,10'r,11's)-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-4',10',11'-triol
(5e)-7-isopropyl-4-methylidene-10-oxoundec-5-enoic acid
(8as)-7-hydroxy-5-methoxy-3,8a-dimethyl-2h,3h-pyrano[2,3-b]pyran-4-one
7-isopropyl-4-methylidene-10-oxoundec-5-enoic acid
(1r,2s,4r,5r,6s,7s,9s,11r)-5-[(2e)-but-2-en-2-yl]-4,11-dimethyl-6-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecane
(1'r,2s,2'r,4's,7'r,10'r,11's)-4'-(acetyloxy)-10'-hydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(1's,2r,2'r,4's,7'r,9'r,10'r,11's)-4',10'-dihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(3r,6s,9r,12s,15r,18s)-3-[(1r)-1-hydroxyethyl]-6,12,15,18-tetraisopropyl-4,10,16-trimethyl-9-(2-methylpropyl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
2-(2-{[2-(2-hydroxy-n,3-dimethylbutanamido)-3-methylpentanoyl]oxy}-n,3-dimethylbutanamido)-3-methylbutanoic acid
11,17-dihydroxy-3,6,9,12,15,18-hexaisopropyl-4-methyl-1,7,13-trioxa-4,10,16-triazacyclooctadeca-10,16-diene-2,5,8,14-tetrone
(7r)-3,8-dibromo-4,7-dimethoxy-7,8-dimethyl-5h-pyrano[3,2-c]pyran-2-one
C12H14Br2O5 (395.92079140000004)
(7r,8s)-3,8-dibromo-4,7-dimethoxy-7,8-dimethyl-5h-pyrano[3,2-c]pyran-2-one
C12H14Br2O5 (395.92079140000004)
(3r,6s,9r,12s,15r,18s)-3-[(1r)-1-hydroxyethyl]-6,9,12,15,18-pentaisopropyl-4,10,16-trimethyl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-3-[(1e,3e,5s,6s)-5,7-dihydroxy-4,6-dimethylhepta-1,3-dien-1-yl]-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate
(1s,2r,5s,8r)-8-hydroxy-1-[(2r)-3-oxobutan-2-yl]-2-[(1e,3e)-penta-1,3-dien-1-yl]-6-oxabicyclo[3.2.1]oct-3-en-7-one
2-(but-2-en-2-yl)-3-(5,7-dihydroxy-4,6-dimethylhepta-1,3-dien-1-yl)-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate
(2s)-2-[(2r)-2-{[(2r)-2-[(2r)-2-hydroxy-n,3-dimethylbutanamido]-3-methylbutanoyl]oxy}-n,3-dimethylbutanamido]-3-methylbutanoic acid
(3s,4r,5s,6r,7s,10r)-3,4,7-trihydroxy-3-methyl-1-oxo-10-[(1e,3e)-penta-1,3-dien-1-yl]-2-oxaspiro[4.5]dec-8-en-6-yl acetate
6,12,18-triisopropyl-4,10,16-trimethyl-3-(2-methylpropyl)-9,15-bis(sec-butyl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
C36H63N3O9 (681.4564068000001)
(5e,7r)-7-isopropyl-4-methylidene-10-oxoundec-5-enoic acid
(2s,3s,4e,6e)-7-[(1r,2s,4r,5r,6s,7s,9s,11r)-5-[(2e)-but-2-en-2-yl]-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.0²,⁴.0⁹,¹¹]dodecan-6-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol
methyl (2z,3e,5e,7z,9e)-11-[(1s,4r,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
C22H27NO7 (417.17874320000004)
(8s)-7-hydroxy-4-methoxy-7,8-dimethyl-5h,8h-pyrano[3,2-c]pyran-2-one
(2s)-2-[(2r)-2-{[(2r)-2-[(2r)-2-hydroxy-n,3-dimethylbutanamido]-3-methylpentanoyl]oxy}-n,3-dimethylbutanamido]-3-methylbutanoic acid
(3s,6r,9s,12r,15s,18r)-3-[(2r)-butan-2-yl]-9-[(2s)-butan-2-yl]-6,12,18-triisopropyl-4,10,16-trimethyl-15-(2-methylpropyl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
C36H63N3O9 (681.4564068000001)
6,8-dihydroxy-3-[(2s)-2-hydroxy-4-oxopentyl]isochromen-1-one
(1s,2r,3s,5r,6s,9r)-2-hydroxy-3-methoxy-3-methyl-9-[(1e,3e)-penta-1,3-dien-1-yl]-4,11-dioxatricyclo[4.3.2.0¹,⁵]undec-7-en-10-one
methyl (2e)-3-[3-methyl-5-(3-methylbut-2-en-1-yl)imidazol-4-yl]prop-2-enoate
methyl (9e)-11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
C22H27NO7 (417.17874320000004)
(1s,2r,5s,6r,8r,11r)-11-hydroxy-8-methyl-10-oxo-2-[(1e,3e)-penta-1,3-dien-1-yl]-7,9-dioxatricyclo[6.2.1.0¹,⁶]undec-3-en-5-yl acetate
(3z,6r)-6-[(1s,2r,3s)-3-hydroxy-2,3-dimethylcyclopentyl]-2-methylhept-3-ene-2,6-diol
methyl (2z,3e,5e,7e,9e)-11-[(1s,4r,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
C22H27NO7 (417.17874320000004)
